Skip to main content
An official website of the United States government

Breast Cancer Steering Committee Task Force Rosters

The Breast Immuno-Oncology and Breast Oncology Local Disease task forces of the NCI Breast Cancer Steering Committee were established to provide a forum for in-depth discussion of clinical trial concepts, provide advisory input on trial design, and make recommendations for clinical trial planning meetings.

Breast Immuno-Oncology (BIO) Task Force

Co-chairs

Sylvia Adams, M.D.
New York University Perlmutter Cancer Center  
New York, NY

Elizabeth A. Mittendorf, M.D., Ph.D.
Dana-Farber Cancer Institute 
Boston, MA

 

Members

Justin M. Balko, Pharm.D., Ph.D.
Vanderbilt University Medical Center  
Nashville, TN

Harry Bear, M.D., Ph.D.
Virginia Commonwealth University 
Richmond, VA

Manali Bhave, M.D.
Emory University Winship Cancer Institute 
Atlanta, GA

Thelma Brown
Patient Advocate 
Birmingham, AL

David W. Cescon, M.D.
University of Toronto Princess Margaret Cancer Centre 
Toronto, ON, Canada 

Steven J. Chmura, M.D., Ph.D.
University of Chicago
Chicago, IL

Charmáine Cook 
Patient Advocate
Reno, NV

Joshua Gruber, M.D., Ph.D.
University of Texas Southwestern Medical Center  
Dallas, TX

Christie J. Hilton, D.O.
Allegheny Health Network Cancer Institute 
Pittsburgh, PA

Kevin Kalinsky, M.D., M.S.
Emory University Winship Cancer Institute 
Atlanta, GA

Keith L. Knutson, Ph.D.
Mayo Clinic
Jacksonville, FL

Nathalie Levasseur, M.D., FRCPC 
University of British Columbia
Vancouver, BC, Canada

Jennifer K. Litton, M.D.
University of Texas MD Anderson Cancer Center 
Houston, TX

Heather L. McArthur, M.D., M.P.H.
University of Texas Southwestern Medical Center 
Dallas, TX

Suresh G. Nair, M.D.
Lehigh Valley Topper Cancer Institute 
Allentown, PA

Rita Nanda, M.D.
University of Chicago
Chicago, IL

David B. Page, M.D., M.S.
Providence Cancer Institute 
Portland, OR

Sujata Patil, Ph.D.
Cleveland Clinic
Cleveland, OH

Charles M. Perou, Ph.D.
University of North Carolina Lineberger Comprehensive Cancer Center 
Chapel Hill, NC

Rossanna Pezo, M.D., Ph.D., FRCPC
Sunnybrook Health Sciences Odette Cancer Centre 
Toronto, ON, Canada

Mei-Yin C. Polley, Ph.D.
University of Chicago 
Chicago, IL

Cesar A. Santa-Maria, M.D., M.S.C.I.
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center 
Baltimore, MD

Joseph Sparano, M.D., FACP
Mt. Sinai Tisch Cancer Institute  
New York, NY

Peter Watson, M.A., M.B. B.Chir., FRCPC
British Columbia Cancer Agency 
Vancouver, BC, Canada

NCI CCCT Program Director

Elena Schwartz, Ph.D.
elena.schwartz@nih.gov

 

Breast Oncology Local Disease (BOLD) Task Force

Co-chairs

Simona F. Shaitelman, M.D., Ed.M.
University of Texas MD Anderson Cancer Center
Houston, TX

Alastair Thompson, M.B. Ch.B., MD, FRCS(ED)
Baylor College of Medicine 
Houston, TX

 

Members

Jayant P. Agarwal, M.D.
University of Utah Huntsman Cancer Institute  
Salt Lake City, UT

Hanna Bandos, Ph.D., M.S.
University of Pittsburgh
Pittsburgh, PA

Tanya S. Berrang, M.D., FRCPC
British Columbia Cancer Agency
Victoria, BC, Canada

Ursa Brown-Glaberman, M.D.
University of New Mexico Comprehensive Cancer Center 
Albuquerque, NM

Eileen Connolly, M.D., Ph.D.
Columbia University Medical Center 
New York, NY

Sandra Finestone, Psy.D.
Patient Advocate
Irvine, CA

Gaorav Gupta, M.D., Ph.D.
University of North Carolina Lineberger Comprehensive Cancer Center 
Chapel Hill, NC

Norah L. Henry, M.D., Ph.D.
University of Michigan Health
Ann Arbor, MI

Reshma Jagsi, M.D., D.Phil.
Emory University Winship Cancer Institute 
Atlanta, GA

A. Marilyn Leitch, M.D.
University of Texas Southwestern Medical Center 
Dallas, TX

Joshua M. V. Mammen, M.D., Ph.D., FACS
University of Nebraska Medical Center 
Omaha, NE

Anne Meyn, M.Ed.
Patient Advocate
Houston, TX

Elizabeth A. Mittendorf, M.D., Ph.D.
Dana-Farber Cancer Institute 
Boston, MA

Susanna M. Nazarian, M.D., Ph.D.
Thomas Jefferson University 
Philadelphia, PA

Steven Piantadosi, M.D., Ph.D.
Brigham and Women's Hospital
Boston, MA

Mei-Yin C. Polley, Ph.D.
University of Chicago 
Chicago, IL

Matthew M. Poppe, M.D.
University of Utah Huntsman Cancer Institute
Salt Lake City, UT

Habib Rahbar, M.D., FSBI
University of Washington School of Medicine
Seattle, WA

Andrea L. Richardson, M.D., Ph.D.
Johns Hopkins University
Baltimore, MD

Danielle Rodin, M.D., M.P.H., FRCPC
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada

Samantha Seaward, M.D.
Kaiser Permanente Oakland Medical Center 
Oakland, CA

Karla A. Sepulveda, M.D.
Baylor College of Medicine 
Houston, TX

Candice N. Thompson, M.D.
Stanford University Emeryville Cancer Center
Emeryville, CA

Irene Wapnir, M.D.
Stanford University Medical Center
Stanford, CA

Timothy Whelan, M.D.
Hamilton Health Sciences Juravinski Cancer Centre 
Hamilton, ON, Canada

Wendy A. Woodward, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
Houston, TX

Jean L. Wright, M.D.
Johns Hopkins University 
Baltimore, MD

NCI CCCT Program Director

Elena Schwartz, Ph.D.
elena.schwartz@nih.gov

 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Breast Cancer Steering Committee Task Force Rosters was originally published by the National Cancer Institute.”

Email